Aktie A0LCV5 AFFYMAX, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Affymax, Inc.

Aktien

A0LCV5

US00826A1097

AFFY

Markt geschlossen - OTC Markets
Andere Börsenplätze
 15:30:01 17.05.2024 		% 5 Tage % 1. Jan.
0,0008 USD +6,67 % Intraday Chart für Affymax, Inc. 0,00 % +33,33 %
2013 Transcript : Affymax, Inc. - Special Call
2013 Transcript : Affymax, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-10-2013 01:00 PM

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer
Affymax Seeks Acquisitions
Affymax, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2014
Affymax Terminates Omontys' Product Collaboration and License Agreement with Takeda Pharmaceutical Company, Effective September 10, 2014
Affymax and Takeda Announce Termination of Omontys(R) (peginesatide) Product Collaboration and License Agreement
Affymax To Review Strategic Options
Affymax, Inc. Auditor Raises 'Going Concern' Doubt
Affymax, Inc. Executes a Seventh Amendment to Lease Agreement
Affymax, Inc. Announces Management Changes
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Composite Index
Affymax, Inc.(OTCPK:AFFY) dropped from NASDAQ Biotechnology Index
Affymax, Inc. to Terminate John Orwin as Chief Executive Officer After May 15, 2013
Affymax, Inc. to Reduce Workforce Amid Product Investigation
Affymax, Inc. Enters into a Letter Agreement with Oxford Finance Corporation and Silicon Valley Bank
Affymax, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2012
Affymax, Inc. Auditor Raises 'Going Concern' Doubt
Affymax Announces Reduction in Force to Align Resources Around Ongoing Product Investigation
Affymax, Inc. may file for Bankruptcy
Affymax Seeks Strategic Alternatives
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0LCV5 Aktie
  4. Nachrichten Affymax, Inc.
  5. Andere Sprachen